rs587782951
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We identified 20 individuals affected with HCM with or without systolic heart failure and conduction abnormalities in the nine Finnish families with JPH2 p.(Thr161Lys) variant.
|
30235249 |
2018 |
rs17228212
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We undertook association analysis of 7 single nucleotide polymorphism (rs599839, rs17465637, rs2972147, rs6922269, rs1333049, rs501120, and rs17228212) at 7 well established CAD risk loci (1p13.3, 1q41, 2q36.3, 6q25.1, 9p21.3, 10q11.21, and 15q22.33, respectively) in 3,320 subjects diagnosed with systolic heart failure of ischemic aetiology and participating in the COntrolled ROsuvastatin multiNAtional Trial in Heart Failure (CORONA) trial.
|
25528061 |
2014 |
rs1799983
|
|
|
0.010 |
GeneticVariation |
BEFREE |
No association was observed between the G894T polymorphism (Glu298Asp) and prognosis in this sample of Brazilian outpatients with systolic heart failure.
|
23949326 |
2013 |
rs4762
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The CC genotype at T174M was positively associated with sHF (OR 2.81, 95% CI 1.20-6.61, p = 0.018).
|
20861628 |
2010 |
rs1267969615
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We assessed the relations among polymorphism of the angiotensin-converting enzyme gene, angiotensinogen M235T (AGT) gene, and angiotensin type I receptor A1166C gene with left ventricular systolic function, left and right ventricular diastolic function, serum angiotensin-converting enzyme, plasma aldosterone and atrial natriuretic peptide levels at presentation, and clinical outcome at 1 year (survival, hospital admissions) in a cohort of Chinese patients with typical systolic heart failure (n = 82).
|
10097225 |
1999 |
rs699
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We assessed the relations among polymorphism of the angiotensin-converting enzyme gene, angiotensinogen M235T (AGT) gene, and angiotensin type I receptor A1166C gene with left ventricular systolic function, left and right ventricular diastolic function, serum angiotensin-converting enzyme, plasma aldosterone and atrial natriuretic peptide levels at presentation, and clinical outcome at 1 year (survival, hospital admissions) in a cohort of Chinese patients with typical systolic heart failure (n = 82).
|
10097225 |
1999 |